NCT07063901View on ClinicalTrials.gov

Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions

Esophagus Cancer

Trial Locations (1)

410011

The Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Central South University

OTHER